PH25503A - Method of medical treatment - Google Patents

Method of medical treatment

Info

Publication number
PH25503A
PH25503A PH36241A PH36241A PH25503A PH 25503 A PH25503 A PH 25503A PH 36241 A PH36241 A PH 36241A PH 36241 A PH36241 A PH 36241A PH 25503 A PH25503 A PH 25503A
Authority
PH
Philippines
Prior art keywords
medical treatment
methyl
treatment
carbazol
imidazol
Prior art date
Application number
PH36241A
Other languages
English (en)
Inventor
Michael Brian Tyers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PH25503A publication Critical patent/PH25503A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Connection Of Batteries Or Terminals (AREA)
  • Saccharide Compounds (AREA)
  • Electrotherapy Devices (AREA)
PH36241A 1986-12-17 1987-12-16 Method of medical treatment PH25503A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868630071A GB8630071D0 (en) 1986-12-17 1986-12-17 Medicaments

Publications (1)

Publication Number Publication Date
PH25503A true PH25503A (en) 1991-07-24

Family

ID=10609112

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36241A PH25503A (en) 1986-12-17 1987-12-16 Method of medical treatment

Country Status (18)

Country Link
US (1) US4835173A (enExample)
EP (1) EP0276559B1 (enExample)
JP (1) JP2732844B2 (enExample)
KR (1) KR880007073A (enExample)
AT (1) ATE79031T1 (enExample)
AU (1) AU608794B2 (enExample)
CY (1) CY1693A (enExample)
DE (1) DE3780940T2 (enExample)
DK (1) DK662787A (enExample)
ES (1) ES2051754T3 (enExample)
GB (1) GB8630071D0 (enExample)
GR (1) GR3005682T3 (enExample)
HK (1) HK36593A (enExample)
IE (1) IE60135B1 (enExample)
IL (1) IL84844A0 (enExample)
NZ (1) NZ222949A (enExample)
PH (1) PH25503A (enExample)
ZA (1) ZA879458B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63277622A (ja) * 1986-12-17 1988-11-15 グラクソ、グループ、リミテッド 医薬
US5246941A (en) * 1986-12-17 1993-09-21 Glaxo Group Limited Method for the treatment of depression
US5221687A (en) * 1988-09-01 1993-06-22 Glaxo Group Limited Medicaments
GB8820653D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
US5180728A (en) * 1989-09-25 1993-01-19 Fujisawa Pharmaceutical Company, Ltd. Pyrimidoindole derivatives and processes for preparation thereof
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
JPH06508836A (ja) * 1991-06-26 1994-10-06 セプラコア，インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
US6548082B1 (en) 1999-03-01 2003-04-15 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron
AU2002230935A1 (en) * 2000-10-30 2002-05-15 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
SK9892003A3 (en) * 2001-01-11 2004-05-04 Teva Pharma An improved process for preparing pure ondansetron hydrochloride dihydrate
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
DK1499623T3 (da) * 2002-04-29 2007-10-08 Teva Gyogyszerg Ar Zartkoeruee Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-on
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
KR20040104677A (ko) * 2002-04-30 2004-12-10 비오갈 기오기스제르갸르 알티. 신규의 온단세트론 결정 형태, 그 제조 방법, 그 신규의결정 형태를 함유하는 약학 조성물 및 이들을 이용한구역질 치료 방법
HU225885B1 (en) * 2002-10-17 2007-11-28 Richter Gedeon Nyrt Process for producing ondansetron hydrochlorid dihydrate of high purity
US20110034442A1 (en) * 2007-08-08 2011-02-10 Jaun Jose Legarda Ibanez Use and Methods of Use for an Antagonist of the Serotin3 Receptor (5-HT3) and a Selective Modulator of Chloride Channels for the Treatment of Addiction to or Dependence on Medicines/Drugs or Nervous System Disorders
BR112020023132A2 (pt) 2018-06-21 2021-02-09 Société des Produits Nestlé S.A. composições e métodos que usam um precursor de nicotinamida adenina dinucleotídeo (nad+) e pelo menos uma cetona ou um precursor de cetona

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN158970B (enExample) * 1981-06-09 1987-02-28 Ici Plc
GB8401888D0 (en) * 1984-01-25 1984-02-29 Glaxo Group Ltd Heterocyclic compounds
SE460359B (sv) * 1984-01-25 1989-10-02 Glaxo Group Ltd 3-imidazolylmetyltetrahydrokarbazoloner, foerfarande foer framstaellning av dessa och en farmaceutisk komposition
EP0201165B1 (en) * 1985-03-14 1994-07-20 Beecham Group Plc Medicaments for the treatment of emesis
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
HU895334D0 (en) * 1986-07-30 1990-01-28 Sandoz Ag Process for the preparation of nasal pharmaceutical compositions

Also Published As

Publication number Publication date
KR880007073A (ko) 1988-08-26
IE60135B1 (en) 1994-06-01
US4835173A (en) 1989-05-30
ES2051754T3 (es) 1994-07-01
EP0276559A3 (en) 1989-10-18
JPS63165314A (ja) 1988-07-08
DE3780940T2 (de) 1992-12-24
IL84844A0 (en) 1988-06-30
CY1693A (en) 1994-01-14
NZ222949A (en) 1997-06-24
GB8630071D0 (en) 1987-01-28
EP0276559A2 (en) 1988-08-03
DK662787A (da) 1988-06-18
AU608794B2 (en) 1991-04-18
JP2732844B2 (ja) 1998-03-30
ZA879458B (en) 1988-11-30
GR3005682T3 (enExample) 1993-06-07
IE873415L (en) 1988-06-17
ATE79031T1 (de) 1992-08-15
AU8261787A (en) 1988-06-23
HK36593A (en) 1993-04-23
DK662787D0 (da) 1987-12-16
EP0276559B1 (en) 1992-08-05
DE3780940D1 (de) 1992-09-10

Similar Documents

Publication Publication Date Title
PH25503A (en) Method of medical treatment
SE8503680D0 (sv) Indolderivat
FR2624720B1 (fr) Implant pour dispositif d'osteosynthese, notamment du rachis
HU9502193D0 (en) Combination treatment for inhibiting bone loss
AU1808488A (en) Compounds for the treatment of alzheimer's disease
IE873414L (en) Medicament for dementia
IT1238825B (it) Dispositivo per la correzione chirurgica dell'ametropia.
HU902004D0 (en) New trombolitic preparations
IE873231L (en) Medicaments
GR3005231T3 (enExample)
EP1263495A4 (en) CANNULATION SYSTEM RELATED METHODS
GB8600666D0 (en) Apparatus for surgical & medical uses
李虎容 et al. OCCLUSAL CONSIDERATION FOR IMPLANTS
TW217382B (enExample)
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.
CS754186A1 (en) Aid for medical instruments' introduction
FI882378A7 (fi) Tandlaekarens patientstol.
IT1216064B (it) Procedimento per il riempimento e/o l'otturazione in interventi chirurgici e odontoiatrici.
GEP19991579B (en) Method for Shunting of Arteries